Anest Iwata Corp
TSE:6381
Anest Iwata Corp
Cost of Revenue
Anest Iwata Corp
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Anest Iwata Corp
TSE:6381
|
Cost of Revenue
-¥28.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-7%
|
|
Mitsubishi Heavy Industries Ltd
TSE:7011
|
Cost of Revenue
-¥3.6T
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-4%
|
|
Yaskawa Electric Corp
TSE:6506
|
Cost of Revenue
-¥363.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Makita Corp
TSE:6586
|
Cost of Revenue
-¥527.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-8%
|
|
Fanuc Corp
TSE:6954
|
Cost of Revenue
-¥528.4B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-9%
|
|
Daifuku Co Ltd
TSE:6383
|
Cost of Revenue
-¥493.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
See Also
What is Anest Iwata Corp's Cost of Revenue?
Cost of Revenue
-28.9B
JPY
Based on the financial report for Dec 31, 2023, Anest Iwata Corp's Cost of Revenue amounts to -28.9B JPY.
What is Anest Iwata Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-7%
Over the last year, the Cost of Revenue growth was -8%. The average annual Cost of Revenue growth rates for Anest Iwata Corp have been -11% over the past three years , -6% over the past five years , and -7% over the past ten years .